A major international collaboration led by Melbourne researchers has discovered that the world’s most widespread malaria parasite infects humans by hijacking a protein the body cannot live without.
The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
The study, led by the Walter and Eliza Hall Institute’s Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, found that the deadly malaria parasite Plasmodium vivax (P. vivax) causes infection through latching onto the human transferrin receptor protein, which is crucial for iron delivery into the body’s young red blood cells.
Published today in Science, the discovery has solved a mystery that researchers have been grappling with for decades.
Associate Professor Tham, who is also a HHMI-Wellcome International Research Scholar, said the collective efforts of teams from Australia, New Zealand, Singapore, Thailand, United Kingdom, United States, Brazil and Germany had brought the world closer to a potential effective vaccine against P.vivax malaria.
“P. vivax currently inflicts a huge burden on global health. It is the most common malaria parasite in countries outside of Africa, with more than 16 million clinical cases recorded each year.
“The parasite can lie dormant in the liver for months on end without causing any symptoms, which makes it very sneaky and difficult to treat,” Associate Professor Tham said.
“We now know that P. vivax is hijacking the human transferrin receptor which is essential for transporting iron into the body’s young red blood cells.
“Being able to stop P. vivax from latching onto this receptor and infliltrating the blood is a major breakthrough and important step towards malaria elimination,” she said.
Dr Gruszczyk said once the teams understood how the parasite was gaining entry into the cells, they were able to design antibodies to block the mode of access.
“Using the Australian Synchrotron in Melbourne, we generated a 3D map of the parasite protein which is the mechanism P. vivax uses to latch onto the human transferrin receptor and enter the young red blood cells.
“This map provided an unprecedented view of the parasite protein’s shape, which guided the design of antibodies to block P. vivax from gaining entry into the human cells,” Dr Gruszczyk said.
Associate Professor Tham said they were thrilled to see the antibodies successfully block P. vivax invasion using parasites from both Thailand and Brazil. “We are now looking to include collaborative partners in the Pacific, so we can further test the effectiveness of our antibodies,” she said.
Study collaborator Dr Jonathan Abraham from Harvard University said the results of the new study aligned with a growing body of evidence that could be used to target multiple infectious diseases.
“Transferrin receptor is also co-opted by five viruses that cause Ebola-like diseases in South America. These diseases are known as New World haemorrhagic fevers.
“Our increasing understanding of how several pathogens are taking advantage of transferrin receptor, means we are getting closer to disrupting infection for a number of deadly diseases,” Dr Abraham said.
Learn more: Hijacker parasite blocked from infiltrating blood
The Latest on: Malaria parasite
[google_news title=”” keyword=”malaria parasite” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- New Study Enlightens Cause of Drug Resistance in Malaria Parasiteon May 17, 2024 at 11:30 pm
Study shows link between drug resistance of malaria parasite and changes in transfer Ribonucleic acid (tRNA); indicating potential for new treatment approaches.
- Professional Faqs: How Can We Prevent Malaria?on May 16, 2024 at 2:28 pm
Use of anti-malarial drugs to prevent the development of malaria is known as chemoprophylaxis. The choice of chemoprophylaxis varies depending on the species and drug resistance prevalent in a country ...
- Biology GCSE: Infested with malariaon May 16, 2024 at 11:29 am
In this short film Dr Michael Mosley investigates the parasite Plasmodium that carries malaria. This disease kills more than half a million people per year. He gives a sample of his blood to the ...
- Landscape drives zoonotic malaria prevalence in non-human primateson May 16, 2024 at 8:44 am
Regional meta-analysis enriches our understanding of zoonotic malaria in primate reservoirs in areas of Southeast Asia experiencing deforestation, with wider ecological implications for human disease ...
- Research identifies mechanism behind drug resistance in malaria parasiteon May 16, 2024 at 8:15 am
Collaborating researchers have discovered a link between malaria parasites' ability to develop resistance to antimalarial drugs—specifically artemisinin (ART)—through a cellular process called ...
- SMART breakthrough research identifies mechanism behind drug resistance in malaria parasiteon May 15, 2024 at 5:00 pm
Malaria is a mosquito-borne infectious disease that remains a significant global health threat. In 2022, it afflicted 249 million people and caused 608,000 deaths globally. Artemisinin (ART) -based ...
- SMART researchers identify key mechanism behind artemisinin resistance in malariaon May 15, 2024 at 5:00 pm
This breakthrough discovery advances the understanding of how malaria parasites respond to drug-induced stress and develop resistance and paves the way for the development of new drugs to combat ...
- Over 140 malaria cases reported in Vietnamon May 15, 2024 at 6:13 am
HANOI: Vietnam has recorded 141 cases of malaria since early this year, an increase of 107.4 per cent over the same period in 2023, Xinhua quoted Vietnam News on Wednesday (May 15), citing the ...
- Next-Gen malaria jabs can achieve WHO strategic goalon May 15, 2024 at 4:21 am
Almost half of the world’s population is at risk of malaria infection with some 249 million people diagnosed with the disease in 2022 ...
- Malaria still poses health riskson May 13, 2024 at 10:17 pm
Malaria is caused by a single-celled parasite of the genus Plasmodium. The parasite is transmitted to humans most commonly through mosquito bites. The malaria parasites enter the bloodstream and ...
via Google News and Bing News